{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T17:35:59Z","timestamp":1781199359132,"version":"3.54.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T00:00:00Z","timestamp":1613520000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T00:00:00Z","timestamp":1613520000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Wellcome Seed Fund","award":["108080\/Z\/15\/Z"],"award-info":[{"award-number":["108080\/Z\/15\/Z"]}]},{"DOI":"10.13039\/501100009187","name":"Medical Research Foundation","doi-asserted-by":"publisher","award":["MR\/N013514\/1"],"award-info":[{"award-number":["MR\/N013514\/1"]}],"id":[{"id":"10.13039\/501100009187","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasites Vectors"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Asymptomatic\n                      <jats:italic>Leishmania<\/jats:italic>\n                      infections outnumber clinical infections on the Indian subcontinent (ISC), where disease reservoirs are anthroponotic. Diagnostics which detect active asymptomatic infection, which are suitable for monitoring and surveillance, may be of benefit to the visceral leishmaniasis (VL) elimination campaign on the ISC.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Quantitative polymerase chain reaction (qPCR), loop-mediated isothermal amplification (LAMP), and the direct agglutination test (DAT) were carried out on blood samples, and the\n                      <jats:italic>Leishmania<\/jats:italic>\n                      antigen ELISA was carried out on urine samples collected from 720 household and neighbouring contacts of 276 VL and post\u2013kala-azar dermal leishmaniasis (PKDL) index cases, with no symptoms or history of VL or PKDL, in endemic regions of Bangladesh between September 2016 and March 2018.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of the 720 contacts of index cases, asymptomatic infection was detected in 69 (9.6%) participants by a combination of qPCR (1.0%), LAMP (2.1%), DAT (3.9%), and\n                      <jats:italic>Leishmania<\/jats:italic>\n                      antigen ELISA (3.3%). Only one (0.1%) participant was detected positive by all four diagnostic tests. Poor agreement between tests was calculated using Cohen\u2019s kappa (\n                      <jats:italic>\u03ba<\/jats:italic>\n                      ) statistics; however, the\n                      <jats:italic>Leishmania<\/jats:italic>\n                      antigen ELISA and DAT in combination captured all participants as positive by more than one test. We find evidence for a moderately strong association between the index case being a PKDL case (OR 1.94,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.009), specifically macular PKDL (OR 2.12,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.004), and being positive for at least one of the four tests.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      <jats:italic>Leishmania<\/jats:italic>\n                      antigen ELISA on urine detects active asymptomatic infection, requires a non-invasive sample, and therefore may be of benefit for monitoring transmission and surveillance in an elimination setting in combination with serology. Development of an antigen detection test in a rapid diagnostic test (RDT) format would be of benefit to the elimination campaign.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical Abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1186\/s13071-021-04622-8","type":"journal-article","created":{"date-parts":[[2021,2,18]],"date-time":"2021-02-18T14:01:36Z","timestamp":1613656896000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Detection of asymptomatic Leishmania infection in Bangladesh by antibody and antigen diagnostic tools shows an association with post\u2013kala-azar dermal leishmaniasis (PKDL) patients"],"prefix":"10.1186","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0458-2357","authenticated-orcid":false,"given":"Sophie I.","family":"Owen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faria","family":"Hossain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prakash","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajashree","family":"Chowdhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md. Sakhawat","family":"Hossain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Jewell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isra","family":"Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Picado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinesh","family":"Mondal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily R.","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,17]]},"reference":[{"key":"4622_CR1","first-page":"281","volume":"82","author":"PC Sengupta","year":"1947","unstructured":"Sengupta PC. History of kala-azar in India. Ind Med Gaz. 1947;82:281\u20136.","journal-title":"Ind Med Gaz"},{"key":"4622_CR2","doi-asserted-by":"publisher","first-page":"e2657","DOI":"10.1371\/journal.pntd.0002657","volume":"8","author":"E Hasker","year":"2014","unstructured":"Hasker E, Malaviya P, Gidwani K, Picado A, Ostyn B, Kansal S, et al. Strong association between serological status and probability of progression to clinical visceral leishmaniasis in prospective cohort studies in India and Nepal. PLoS Negl Trop Dis. 2014;8:e2657.","journal-title":"PLoS Negl Trop Dis"},{"key":"4622_CR3","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1093\/cid\/ciu102","volume":"58","author":"OP Singh","year":"2014","unstructured":"Singh OP, Hasker E, Sacks D, Boelaert M, Sundar S. Asymptomatic Leishmania infection: a new challenge for Leishmania control. Clin Infect Dis. 2014;58:1424\u20139.","journal-title":"Clin Infect Dis"},{"key":"4622_CR4","doi-asserted-by":"publisher","first-page":"909","DOI":"10.4269\/ajtmh.2007.76.909","volume":"76","author":"C Bern","year":"2007","unstructured":"Bern C, Haque R, Chowdhury R, Ali M, Kurkjian KM, Vaz L, et al. The epidemiology of visceral leishmaniasis and asymptomatic leishmanial infection in a highly endemic Bangladeshi village. Am J Trop Med Hyg. 2007;76:909\u201314.","journal-title":"Am J Trop Med Hyg"},{"key":"4622_CR5","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.trstmh.2011.08.005","volume":"105","author":"VNR Das","year":"2011","unstructured":"Das VNR, Siddiqui NA, Verma RB, Topno RK, Singh D, Das S, et al. Asymptomatic infection of visceral leishmaniasis in hyperendemic areas of Vaishali district, Bihar, India: a challenge to kala-azar elimination programmes. Trans R Soc Trop Med Hyg. 2011;105:661\u20136.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"4622_CR6","unstructured":"WHO. Process of validation of elimination of kala-azar as a public health problem in South-East Asia. 2016. https:\/\/img1.wsimg.com\/blobby\/go\/c5156b45-48df-4ba4-ab15-be2bb6261d20\/downloads\/1bu1begqv_714167.pdf."},{"key":"4622_CR7","doi-asserted-by":"publisher","first-page":"10","DOI":"10.4103\/2229-5070.129143","volume":"4","author":"M Muniaraj","year":"2014","unstructured":"Muniaraj M. The lost hope of elimination of kala-azar (visceral leishmaniasis) by 2010 and cyclic occurrence of its outbreak in India, blame falls on vector control practices or co-infection with human immunodeficiency virus or therapeutic modalities? Trop Parasitol. 2014;4:10\u20139.","journal-title":"Trop Parasitol"},{"key":"4622_CR8","doi-asserted-by":"publisher","first-page":"147","DOI":"10.2147\/CLEP.S44267","volume":"6","author":"PD Ready","year":"2014","unstructured":"Ready PD. Epidemiology of visceral leishmaniasis. Clin Epidemiol. 2014;6:147\u201354.","journal-title":"Clin Epidemiol"},{"key":"4622_CR9","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0001-706X(00)00141-8","volume":"77","author":"JL Guarga","year":"2000","unstructured":"Guarga JL, Lucientes J, Perib\u00e1\u00f1ez MA, Molina R, Gracia MJ, Castillo JA. Experimental infection of Phlebotomus perniciosus and determination of the natural infection rates of Leishmania infantum in dogs. Acta Trop. 2000;77:203\u20137.","journal-title":"Acta Trop"},{"key":"4622_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2019.02268","author":"D Mondal","year":"2019","unstructured":"Mondal D, Ghosh P, Chowdhury R, Halleux C, Ruiz-Postigo JA, Alim A, et al. Relationship of serum antileishmanial antibody with development of visceral leishmaniasis, post-kala-azar dermal leishmaniasis and visceral leishmaniasis relapse. Front Microbiol. 2019. https:\/\/doi.org\/10.3389\/fmicb.2019.02268.","journal-title":"Front Microbiol"},{"key":"4622_CR11","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1128\/CDLI.5.5.717-720.1998","volume":"5","author":"EE Zijlstra","year":"1998","unstructured":"Zijlstra EE, Daifalla NS, Kager PA, Khalil EAG, El-Hassan AM, Reed SG, et al. RK39 enzyme-linked immunosorbent assay for diagnosis of Leishmania donovani infection. Clin Diagn Lab Immunol. 1998;5:717\u201320.","journal-title":"Clin Diagn Lab Immunol"},{"key":"4622_CR12","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1136\/bmj.38917.503056.7C","volume":"333","author":"F Chappuis","year":"2006","unstructured":"Chappuis F, Rijal S, Soto A, Menten J, Boelaert M. A meta-analysis of the diagnostic performance of the direct agglutination test and rK39 dipstick for visceral leishmaniasis. BMJ. 2006;333:723.","journal-title":"BMJ"},{"key":"4622_CR13","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1128\/jcm.33.7.1742-1745.1995","volume":"33","author":"SEO Meredith","year":"1995","unstructured":"Meredith SEO, Kroon NCM, Sondorp E, Seaman J, Goris MGA, Van Ingen CW, et al. Leish-KIT, a stable direct agglutination test based on freeze-dried antigen for serodiagnosis of visceral leishmaniasis. J Clin Microbiol. 1995;33:1742\u20135.","journal-title":"J Clin Microbiol"},{"key":"4622_CR14","doi-asserted-by":"publisher","first-page":"e237","DOI":"10.1016\/S2214-109X(19)30536-4","volume":"8","author":"K Cloots","year":"2020","unstructured":"Cloots K, Uranw S, Ostyn B, Bhattarai NR, Le Rutte E, Khanal B, et al. Impact of the visceral leishmaniasis elimination initiative on Leishmania donovani transmission in Nepal: a 10-year repeat survey. Lancet Glob Health. 2020;8:e237\u201343.","journal-title":"Lancet Glob Health"},{"key":"4622_CR15","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1128\/CVI.00473-10","volume":"18","author":"K Gidwani","year":"2011","unstructured":"Gidwani K, Picado A, Ostyn B, Singh SP, Kumar R, Khanal B, et al. Persistence of Leishmania donovani antibodies in past visceral leishmaniasis cases in India. Clin Vaccine Immunol. 2011;18:346\u20138.","journal-title":"Clin Vaccine Immunol"},{"key":"4622_CR16","doi-asserted-by":"publisher","first-page":"e0185606","DOI":"10.1371\/journal.pone.0185606","volume":"12","author":"F Hossain","year":"2017","unstructured":"Hossain F, Ghosh P, Khan MAA, Duthie MS, Vallur AC, Picone A, et al. Real-time PCR in detection and quantitation of Leishmania donovani for the diagnosis of visceral leishmaniasis patients and the monitoring of their response to treatment. PLoS ONE. 2017;12:e0185606.","journal-title":"PLoS ONE"},{"key":"4622_CR17","doi-asserted-by":"publisher","first-page":"e00386","DOI":"10.1128\/JCM.00386-18","volume":"56","author":"ER Adams","year":"2018","unstructured":"Adams ER, Schoone G, Versteeg I, Gomez MA, Diro E, Mori Y, et al. Development and evaluation of a novel loop-mediated isothermal amplification assay for diagnosis of cutaneous and visceral leishmaniasis. J Clin Microbiol. 2018;56:e00386-e418.","journal-title":"J Clin Microbiol"},{"key":"4622_CR18","doi-asserted-by":"publisher","first-page":"e0006264","DOI":"10.1371\/journal.pntd.0006264","volume":"12","author":"M Mukhtar","year":"2018","unstructured":"Mukhtar M, Ali SS, Boshara SA, Albertini A, Monnerat S, Bessell P, et al. Sensitive and less invasive confirmatory diagnosis of visceral leishmaniasis in Sudan using loop-mediated isothermal amplification (LAMP). PLoS Negl Trop Dis. 2018;12:e0006264.","journal-title":"PLoS Negl Trop Dis"},{"key":"4622_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-015-1125-3","volume":"15","author":"AC Vallur","year":"2015","unstructured":"Vallur AC, Tutterrow YL, Mohamath R, Pattabhi S, Hailu A, Abdoun AO, et al. Development and comparative evaluation of two antigen detection tests for visceral leishmaniasis. BMC Infect Dis. 2015;15:1\u201310.","journal-title":"BMC Infect Dis"},{"key":"4622_CR20","doi-asserted-by":"publisher","first-page":"e2053","DOI":"10.1371\/journal.pntd.0002053","volume":"7","author":"E Hasker","year":"2013","unstructured":"Hasker E, Kansal S, Malaviya P, Gidwani K, Picado A, Singh RP, et al. Latent Infection with Leishmania donovani in highly endemic villages in Bihar, India. PLoS Negl Trop Dis. 2013;7:e2053.","journal-title":"PLoS Negl Trop Dis"},{"key":"4622_CR21","unstructured":"Oliveros JC. Venny. An interactive tool for comparing lists with Venn\u2019s diagrams. (2007\u20132015). https:\/\/bioinfogp.cnb.csic.es\/tools\/venny\/index.html."},{"key":"4622_CR22","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1093\/aje\/kwt286","volume":"179","author":"M van Smeden","year":"2014","unstructured":"van Smeden M, Naaktgeboren CA, Reitsma JB, Moons KGM, de Groot JAH. Latent class models in diagnostic studies when there is no reference standard\u2013a systematic review. Am J Epidemiol. 2014;179:423\u201331.","journal-title":"Am J Epidemiol"},{"key":"4622_CR23","unstructured":"Marshall J. Latent class analysis in R. 2015. https:\/\/raw.githubusercontent.com\/jmarshallnz\/lcar\/master\/lca.R."},{"key":"4622_CR24","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1128\/JCM.02620-15","volume":"54","author":"AC Vallur","year":"2016","unstructured":"Vallur AC, Reinhart C, Mohamath R, Goto Y, Ghosh P, Mondal D, et al. Accurate serodetection of asymptomatic Leishmania donovani infection by use of defined antigens. J Clin Microbiol. 2016;54:1025\u201330.","journal-title":"J Clin Microbiol"},{"key":"4622_CR25","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1093\/trstmh\/trw027","volume":"110","author":"SS Banu","year":"2016","unstructured":"Banu SS, Meyer W, Ahmed B-N, Kim R, Lee R. Detection of Leishmania donovani in peripheral blood of asymptomatic individuals in contact with patients with visceral leishmaniasis. Trans R Soc Trop Med Hyg. 2016;110:286\u201393.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"4622_CR26","doi-asserted-by":"publisher","first-page":"e0008272","DOI":"10.1371\/journal.pntd.0008272","volume":"14","author":"VN Rabi Das","year":"2020","unstructured":"Rabi Das VN, Bimal S, Siddiqui NA, Kumar A, Pandey K, Sinha SK, et al. Conversion of asymptomatic infection to symptomatic visceral leishmaniasis: a study of possible immunological markers. PLoS Negl Trop Dis. 2020;14:e0008272.","journal-title":"PLoS Negl Trop Dis"},{"key":"4622_CR27","doi-asserted-by":"publisher","first-page":"e0004896","DOI":"10.1371\/journal.pntd.0004896","volume":"10","author":"S Hirve","year":"2016","unstructured":"Hirve S, Boelaert M, Matlashewski G, Mondal D, Arana B, Kroeger A, et al. Transmission dynamics of visceral leishmaniasis in the Indian Subcontinent\u2014a systematic literature review. PLoS Negl Trop Dis. 2016;10:e0004896.","journal-title":"PLoS Negl Trop Dis"},{"key":"4622_CR28","unstructured":"World Health Organisation. Ending the neglect to attain the sustainable development goals: a road map for neglected tropical diseases 2021\u20132030. 2020. http:\/\/apps.who.int\/bookorders."},{"key":"4622_CR29","doi-asserted-by":"publisher","first-page":"e599","DOI":"10.1371\/journal.pntd.0000599","volume":"4","author":"C Bern","year":"2010","unstructured":"Bern C, Courtenay O, Alvar J. Of cattle, sand flies and men: a systematic review of risk factor analyses for South Asian visceral leishmaniasis and implications for elimination. PLoS Negl Trop Dis. 2010;4:e599.","journal-title":"PLoS Negl Trop Dis"},{"key":"4622_CR30","doi-asserted-by":"publisher","first-page":"655","DOI":"10.3201\/eid1105.040718","volume":"11","author":"C Bern","year":"2005","unstructured":"Bern C, Hightower AW, Chowdhury R, Ali M, Amann J, Wagatsuma Y, et al. Risk factors for kala-azar in Bangladesh. Emerg Infect Dis. 2005;11:655\u201362.","journal-title":"Emerg Infect Dis"},{"key":"4622_CR31","doi-asserted-by":"publisher","first-page":"e0006803","DOI":"10.1371\/journal.pntd.0006803","volume":"12","author":"LAC Chapman","year":"2018","unstructured":"Chapman LAC, Morgan ALK, Adams ER, Bern C, Medley GF, D\u00e9 Irdre Hollingsworth T. Age trends in asymptomatic and symptomatic Leishmania donovani infection in the Indian subcontinent: a review and analysis of data from diagnostic and epidemiological studies. PLoS Negl Trop Dis. 2018;12:e0006803.","journal-title":"PLoS Negl Trop Dis"}],"container-title":["Parasites &amp; Vectors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-021-04622-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13071-021-04622-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-021-04622-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,2]],"date-time":"2021-11-02T01:05:47Z","timestamp":1635815147000},"score":1,"resource":{"primary":{"URL":"https:\/\/parasitesandvectors.biomedcentral.com\/articles\/10.1186\/s13071-021-04622-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,17]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["4622"],"URL":"https:\/\/doi.org\/10.1186\/s13071-021-04622-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.05.26.20113431","asserted-by":"object"}]},"ISSN":["1756-3305"],"issn-type":[{"value":"1756-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,17]]},"assertion":[{"value":"11 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Ethical Review Committee (ERC) of the icddr,b (PR-14093). Adult participants provided written informed consent, and in the case of any participants under 18\u00a0years of age, a parent or guardian provided informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"111"}}